Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination - Wikidata - wikimedia - TriplyDB

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

http://www.wikidata.org/entity/Q28236770

about

DNA vaccines: a simple DNA sensing matter?Proteomic study of differential protein expression in mouse lung tissues after aerosolized ricin poisoning.HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivo Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis.Technologies for enhanced efficacy of DNA vaccines.Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity.Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.Life after death: targeting high mobility group box 1 in emergent cancer therapies.Harnessing DNA-induced immune responses for improving cancer vaccines.Nasal immunization using a mimovirus vaccine based on the Eppin B-cell epitope induced suppressed fertility in mice.Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab.HMGB1-LPS complex promotes transformation of osteoarthritis synovial fibroblasts to a rheumatoid arthritis synovial fibroblast-like phenotype IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology.DNA-based influenza vaccines as immunoprophylactic agents toward universality.High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines.Synergistic effect of high-mobility group box-1 and lipopolysaccharide on cytokine induction in bovine peripheral blood mononuclear cells.Suppression of breast tumor growth by DNA vaccination against phosphatase of regenerating liver 3.An optimized HMGB1 expressed by recombinant rabies virus enhances immunogenicity through activation of dendritic cells in mice.Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections.A Review of DNA Vaccines Against Influenza

P2860

Q26859016-1F103181-97F7-44CA-BCCB-80BCE2097FF1 Q33755546-EC922E4C-7053-44E9-AB43-D541D503686F Q35082880-1B9AFB67-650A-49AD-A19F-AEFDC1EAF6CC Q35406168-73D9375E-2653-4841-9B98-A3D8C651AC32 Q35802958-C15FA736-70B9-4D26-82B4-6D61D59BB368 Q35826673-E1D65B7C-353D-4330-8730-2D31F51B5BFD Q35826774-0BE3E175-5913-4B5A-BDB3-C1451FCD87A9 Q35902972-C298D6B2-B358-4186-91C1-E74EC73D37DB Q36562901-27F53490-FCEA-4F46-8491-67DCF0108EF9 Q36694866-DC5B3AE0-5033-4A0C-9247-0D926C34AD0A Q36978339-AEDC08DA-B160-4219-8DED-563D54D73F94 Q37530545-CE293D4C-0128-43FC-8CBE-5BB10B233404 Q37620697-9522C421-DF8A-467A-9213-11ACF5E9F322 Q38005217-45A5E2A9-FF62-4271-B6F7-598F94C5E6B6 Q38670879-6F38FA6D-2078-43B5-AD68-5E94867F6DDF Q39042197-56296035-C8D2-41F9-A659-E6904A4235F7 Q40239891-B593118A-DB5B-4C15-BC1C-A9A39CD58074 Q43522873-B0AF8D53-4D01-450F-86F2-0DB1C21F7B82 Q45034708-1F49F279-05FC-44F5-B3D3-D7D53CCC40AA Q50220559-D779F7C4-0D43-46F1-9958-7350588B1DB8 Q52657377-1D2F6B56-E77B-49EA-AE0A-A2825E5E7F4F Q57094261-2EEB4C32-99C2-4934-9BA1-223E1FA4BA9D

P2860

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

http://www.wikidata.org/entity/Q28236770

description

2011 nî lūn-bûn

@nan

2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@ast

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@en

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@nl

type

label

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@ast

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@en

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@nl

prefLabel

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@ast

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@en

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@nl

P1433

Q28236770-10C8DE44-EB6D-4EC3-B3D5-360985B54324

P1476

Q28236770-2BCC97E9-FB66-492B-8F27-BC94D35730F2

P2093

Q28236770-1D2FA518-F0A7-4848-A27E-4270560F3BE4

Q28236770-4124AE3C-B8A1-4A26-81C3-EDFA4E07B6FC

Q28236770-5020B0BC-8B4A-4F3D-A7F8-DA56EAF2B4D7

Q28236770-78E2CA58-525F-43BD-ACBC-795A2220F4F4

Q28236770-A3AFF6B2-7F92-46F1-9B37-BF0919BA42C5

Q28236770-ACB69C21-CC1C-47FC-BFBE-815EB7D28133

Q28236770-ACE659E1-EA74-405C-92B1-532C3D252B00

Q28236770-C20EB46F-6E7E-4834-9F41-4C7666FD3005

Q28236770-E0BCFBCC-E351-4BE0-A15D-B330C3FF2B75

P2860

Q28236770-006A2E22-2E44-452B-83ED-411C8DA80EC6

Q28236770-08ACA911-AC78-412C-AA2F-866283DF051E

Q28236770-0916CCC7-07C9-4D9A-8306-24C408AEAB50

Q28236770-0A0793B8-14C4-442D-9EDB-D3AE717B216F

Q28236770-0A959B89-2325-402A-83B0-7A8E84CDA11B

Q28236770-1587BF81-52E8-475D-8606-10F471C9EA0B

Q28236770-1BA1617A-54C5-41D3-9D73-58B0D66A80F8

Q28236770-223C4E0E-F564-4386-B1EC-D3BDBD6EB53F

Q28236770-293C90DB-85B3-4A08-8389-3735D2605B60

Q28236770-2A589610-AE46-46B4-9ADB-F60DB7FF114A

P2888

Q28236770-FBD9AC80-9FF8-4B6A-916A-D8EE2E442329

P304

Q28236770-623305BD-5A59-4A1C-B78E-81C6801B5F83

P31

Q28236770-02207209-3ACA-44BB-8992-E7E1A85655DF

P356

Q28236770-6488ACF0-CD1B-49DC-AE77-F0A2F70B5592

P407

Q28236770-9763367E-06A0-4D1A-B1EF-584F6DCFD8DD

P433

Q28236770-E39F1CCF-1C0C-4548-8FFE-2ECA88D05F73

P478

Q28236770-B803ADC4-CA8C-47F4-AA41-28E27AF9AB8B

P50

Q28236770-A6841B35-6251-428B-98DC-4B018DA73AA8

Q28236770-F0A6BBAA-1C6A-4DDF-8FC5-43D1248EEF7F

P577

Q28236770-F6A6F47D-6488-4D06-8FE7-8FE6CF2D0870

P5875

Q28236770-C84075F2-1C09-4AD5-B742-5017190A855C

P698

Q28236770-C2B7099A-3CF1-4773-A6BA-03E47561B9AE

P932

Q28236770-987849DA-ACCA-406B-AF7D-33FEC5B509D8

P356

P1433

P1476

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

@en

P2093

A Patel

http://www.w3.org/2001/XMLSchema#string

D B Weiner

http://www.w3.org/2001/XMLSchema#string

D Gupta

http://www.w3.org/2001/XMLSchema#string

D J Shedlock

http://www.w3.org/2001/XMLSchema#string

G P Kobinger

http://www.w3.org/2001/XMLSchema#string

H Bao

http://www.w3.org/2001/XMLSchema#string

J Yan

http://www.w3.org/2001/XMLSchema#string

M P Morrow

http://www.w3.org/2001/XMLSchema#string

O U Kawalekar

http://www.w3.org/2001/XMLSchema#string

P2860

The HIV-1 Vpr and glucocorticoid receptor complex is a gain-of-function interaction that prevents the nuclear localization of PARP-1

Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity

Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus

Immunogenicity of novel consensus-based DNA vaccines against avian influenza.

Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.

Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens.

DNA vaccines: a key for inducing long-term cellular immunity.

Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Plasmid injection and application of electric pulses alter endogenous mRNA and protein expression in B16.F10 mouse melanomas

Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

P2888

P304

1070-1077

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/GT.2011.59

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Karuppiah Muthumani

P577

2011-05-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51099774

http://www.w3.org/2001/XMLSchema#string

P698

21544096

http://www.w3.org/2001/XMLSchema#string

P932

4141626

http://www.w3.org/2001/XMLSchema#string